dm+d

Unassigned

New Medicines

Clostridium difficile infection - prevention of recurrence

Information

Faecal Microbiota for Transplantation (FMT) product
Ferring
Ferring

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Immunomodulator. RBX2660 is a suspension in a ready-to-use enema formulation that contains live microbes designed to rebuild a healthy intestinal microbiome, known as a FMT (Faecal Microbiota for Transplantation) product.
A total of 13,286 cases of C.difficile infection were reported by hospitals in 2017-18, an increase of 3.4% from 2016/17 and a decrease of 76.1% from 2007/08.[9]
Clostridium difficile infection - prevention of recurrence
Rectal

Evidence based evaluations